Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Dr. Joel Kaplan Inc.
WARNING LETTER
•Dr. Joel Kaplan Inc.•July 17, 2013

FDA WARNING_LETTER - Dr. Joel Kaplan Inc. - July 17, 2013

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

On May 1, 2014, the FDA issued a Warning Letter to Dr. Joel Kaplan, Inc. following an inspection from June 19 to July 17, 2013. The firm, operating from a retail store and websites (www.drjoelkaplan.com, www.getbiggertoday.com), manufactures and sells the MegaVac System (an external penile rigidity device) and the Clitoris Enhancement System, along with dietary supplements.

The MegaVac System was found to be adulterated under 21 U.S.C. § 351(h) due to non-conformity with Quality System (QS) regulation (21 CFR Part 820). Specific violations included failure to maintain device history records (21 CFR 820.184) for repacked MegaVac pumps and failure to establish complaint handling procedures (21 CFR 820.198(a)).

Furthermore, the MegaVac System was deemed adulterated under 21 U.S.C. § 351(f)(1)(B) because the firm lacked an approved premarket approval (PMA) or investigational device exemption (IDE). It was also misbranded under 21 U.S.C. § 352(o) for major changes to its intended use (e.g., penis enlargement, curvature correction) without

Company
Dr. Joel Kaplan Inc.
Inspection Date
July 17, 2013
Product Type
Devices
Office
Los Angeles District Office
People
  • Alonza E. Cruse (Director)
  • Hugo Cornejo (Cofounder )
Open in Dashboard

ID · a4ff8472-309f-4017-868d-ffd3f515db4e

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.18421 CFR 820.198(a)21 U.S.C. 351(f)(1)(B)21 U.S.C. 360e(a)21 U.S.C. 360j(g)21 U.S.C. 352(o)21 U.S.C. 360(k)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.